Compare ACADIA Pharmaceuticals Inc. (ACAD) vs Global X Defense Tech ETF (SHLD) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ACADIA Pharmaceuticals Inc. vs Global X Defense Tech ETF — how do they compare? ACADIA Pharmaceuticals Inc. trades at $25.99 (market cap $4.49B), while Global X Defense Tech ETF trades at $62.56. The key difference: ACADIA Pharmaceuticals Inc. is trading nearer its 52-week high, Global X Defense Tech ETF nearer its low. Which is the better fit depends on your goals.
| ACAD | SHLD | |
|---|---|---|
Market Cap | $4.49B | — |
Sector | Health | Sector/Thematic |
52-Week High | $28.06 | $78.02 |
52-Week Low | $20.06 | $58.20 |
Enterprise Value | $3.69B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
SHLD (Global X Defense Tech ETF) trades at $64.84, up 1.38% with a bullish technical signal supported by moving averages and ADX indicators. The defense sector benefits from global military spending growth, with recent UK defense overhaul and Pentagon AI investments driving positive sentiment. The ETF provides diversified exposure to defense technology companies amid accelerating global rearmament trends.
The outlook remains positive given structural defense spending increases, though competition from other defense ETFs and valuation concerns present risks. Technical indicators suggest potential resistance near $65-66 levels, while sector momentum supports continued investor interest in defense technology exposure.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ACADIA Pharmaceuticals Inc.
Acadia Pharmaceuticals is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecule drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.
Read more on ACAD →About Global X Defense Tech ETF
SHLD tracks the Global X Defense Tech Index, targeting companies that lead the technological transformation of the defense sector. It focuses on pure-play innovators in cybersecurity, artificial intelligence, robotics, and advanced military systems, excluding traditional commercial aerospace to maintain a high level of thematic purity.
Read more on SHLD →
